Eribulin for the Treatment of Metastatic Breast Cancer: An Update on Its Safety and Efficacy

International Journal of Women's Health - New Zealand
doi 10.2147/ijwh.s74462
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Eribulin Mesylate in the Treatment of Metastatic Breast Cancer

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2012English

Outcome of Eribulin as a Late Treatment Line for Thai Metastatic Breast Cancer Patients

OncoTargets and Therapy
OncologyPharmacology
2018English

Use of Eribulin as an Earlier-Line Chemotherapy for Patients With HER2-negative Metastatic Breast Cancer

Journal of Cancer
Oncology
2020English

Efficacy of Eribulin in Breast Cancer: A Short Report on the Emerging New Data

OncoTargets and Therapy
OncologyPharmacology
2017English

Eribulin Suppresses New Metastases in Patients With Metastatic Breast Cancer

In Vivo
BiochemistryMedicineGeneticsPharmacologyMolecular Biology
2020English

Efficacy and Safety of Non-Pegylated Liposomal Doxorubicin in Metastatic Breast Cancer Therapy

OnCOReview
Oncology
2017English

Update on the Safety and Efficacy of Teriparatide in the Treatment of Osteoporosis

Therapeutic Advances in Musculoskeletal Disease
RheumatologyOrthopedicsSports Medicine
2019English

Choosing Treatment for Metastatic Breast Cancer.

BMJ
1982English

Long-Term Efficacy and Safety of Exemestane in the Treatment of Breast Cancer

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy